Literature DB >> 15313627

Amyloid fibril formation by a partially structured intermediate state of alpha-chymotrypsin.

Irantzu Pallarès1, Josep Vendrell, Francesc X Avilés, Salvador Ventura.   

Abstract

Here we investigated the effects of 2,2,2-trifluoroethanol (TFE) on the structure of alpha-chymotrypsin. The protein aggregates maximally in 35% (v/v) TFE. Congo red and thioflavin-T binding experiments suggest that the aggregates induced by TFE have amyloid-like properties, and transmission electron microscopy data show that these aggregates have a fibrilar morphology. Fluorescence, circular dichroism, anilino-8-napthalene sulfonate binding, and Fourier-transformed infrared spectroscopy data suggest that formation of a partially structured intermediate state precedes the onset of the aggregation process. The native beta-barrel structure of alpha-chymotrypsin appears to be disrupted in the partially structured intermediate state in favour of a non-native extended beta-sheet conformation with exposed hydrophobic surfaces. The protein becomes "sticky" under these conditions and aggregates into amyloid-like structures. The data support the hypothesis that amyloid formation involves the ordered self-assembly of partially folded species that are critical soluble precursors of fibrilar aggregates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313627     DOI: 10.1016/j.jmb.2004.06.089

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  33 in total

1.  Amyloid fibril formation can proceed from different conformations of a partially unfolded protein.

Authors:  Martino Calamai; Fabrizio Chiti; Christopher M Dobson
Journal:  Biophys J       Date:  2005-09-16       Impact factor: 4.033

2.  A quasi-spontaneous amyloid route in a DNA binding gene regulatory domain: The papillomavirus HPV16 E2 protein.

Authors:  Diana E Wetzler; Eduardo M Castaño; Gonzalo de Prat-Gay
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

3.  Amyloid fibril formation in vitro from halophilic metal binding protein: its high solubility and reversibility minimized formation of amorphous protein aggregations.

Authors:  Yuhei Tokunaga; Mitsuharu Matsumoto; Masao Tokunaga; Tsutomu Arakawa; Yasushi Sugimoto
Journal:  Protein Sci       Date:  2013-09-30       Impact factor: 6.725

4.  Study of cosolvent-induced alpha-chymotrypsin fibrillogenesis: does protein surface hydrophobicity trigger early stages of aggregation reaction?

Authors:  Reza Khodarahmi; Hosnieh Soori; Mojtaba Amani
Journal:  Protein J       Date:  2009-10       Impact factor: 2.371

5.  High-resolution conformation and backbone dynamics of a soluble aggregate of apomyoglobin119.

Authors:  Senapathy Rajagopalan; Neşe Kurt; Silvia Cavagnero
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

6.  Effects of heating or ultrasound treatment on the enzymolysis and the structure characterization of hempseed protein isolates.

Authors:  Shenyan Wang; Juanhong Wang; Feng Xue; Chen Li
Journal:  J Food Sci Technol       Date:  2019-06-06       Impact factor: 2.701

7.  Interplay between desolvation and secondary structure in mediating cosolvent and temperature induced alpha-synuclein aggregation.

Authors:  V L Anderson; W W Webb; D Eliezer
Journal:  Phys Biol       Date:  2012-08-29       Impact factor: 2.583

8.  Conformational transitions provoked by organic solvents in chicken egg ovalbumin: mimicking the local environment.

Authors:  Afshin Iram; Aabgeena Naeem
Journal:  Protein J       Date:  2013-01       Impact factor: 2.371

9.  Ca2+-induced linker transformation leads to a compact and rigid collagen-binding domain of Clostridium histolyticum collagenase.

Authors:  Sagaya T L Philominathan; Osamu Matsushita; Robert Gensure; Joshua Sakon
Journal:  FEBS J       Date:  2009-05-28       Impact factor: 5.542

10.  Amyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases.

Authors:  Virginia Castillo; Salvador Ventura
Journal:  PLoS Comput Biol       Date:  2009-08-21       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.